TITLE

Tissue transplantation

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS104
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `Leflunomide abrogates hyperacute heart allograft rejection in presensitized rats,' by A. Cheung et al.
ACCESSION #
9708176398

 

Related Articles

  • A QUANTITATIVE LYMPH NODE WEIGHT ASSAY FOR ALLOGENEIC INTERACTIONS IN THE RAT. Dorsch, Susan E.; Roser, Bruce // Australian Journal of Experimental Biology & Medical Science;Apr1974, Vol. 52 Issue 2, p253 

    Presents a quantitative lymph node assay for allogeneic interactions in the rat. Methods of measuring allograft responses in vivo; Effect of the injection of allogeneic cells; Kinetics of lymph node enlargement.

  • As allograft use rises, federal regulations ensure safety.  // Orthopedics Today;Feb2009, Vol. 29 Issue 2, p50 

    This article reports on a study which revealed an increase in musculoskeletal allograft use in the U.S.

  • CRYPTIC SPECIES IN SIGMODON HISPIDUS: EVIDENCE FROM DNA SEQUENCES. Peppers, Lottie L.; Bradley, Robert D. // Journal of Mammalogy;May2000, Vol. 81 Issue 2, p332 

    Examines the phylogenetic relationships among subspecies of Sigmodon hispidus with the use of DNA-sequence data. Research methodology; Results and discussion.

  • Leflunomide/methotrexate/sulfasalazine.  // Reactions Weekly;8/28/2010, Issue 1316, p29 

    The article describes the case of a 53-year-old woman who developed various toxicities, such as gastrointestinal (GI) intolerance, hepatocellular injury and allergic skin reaction while receiving leflunomide, methotrexate and sulfasalazine for severe rheumatoid arthritis (RA).

  • Adalimumab/leflunomide/methotrexate.  // Reactions Weekly;5/21/2011, Issue 1352, p6 

    The article describes the case of a 58-year-old woman with rheumatoid arthritis who developed disseminated tuberculosis and pneumocystis while being treated with leflunomide, corticosteroids, methotrexate and adalimumab.

  • Leflunomide.  // Reactions Weekly;5/21/2011, Issue 1352, p24 

    The article describes the case of a 62-year-old woman who developed several multisystem toxicity such as gastroenteritis and septicaemia during treatment with leflunomide.

  • Health Canada: leflunomide and peripheral neuropathy.  // Reactions Weekly;5/1/2010, Issue 1299, p2 

    The article focuses on reports of peripheral neuropathy associated with leflunomide, a class of disease-modifying antirheumatic drug.

  • Leflunomide.  // Reactions Weekly;11/17/2012, Issue 1428, p24 

    The article describes a case of colitis in a 49-year-old woman that developed following treatment with leflunomide for reactive arthritis.

  • Physiologically Based Pharmacokinetic Model for Prediction of Leflunomide and Teriflunomide: Should Consideration Be Given to Cannalicular Efflux Transporters? Srinivas, NR // CPT: Pharmacometrics & Systems Pharmacology;Oct2015, Vol. 4 Issue 10, p563 

    A letter to the article is presented in response to the article "Physiologically Based Pharmacokinetic Model for Prediction of Leflunomide and Teriflunomide: Should Consideration Be Given to Cannalicular Efflux Transporters?" by N. R. Srinivas in the previous issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics